Tesamorelin
FDA-approved GHRH analog for HIV-associated lipodystrophy
Overview
Tesamorelin is an FDA-approved GHRH analog specifically indicated for treatment of HIV-associated lipodystrophy (excess abdominal fat).
Key Information
Mechanism
Stabilized GHRH analog that stimulates endogenous GH production, targeting visceral fat reduction.
Benefits
- FDA-approved
- Reduces visceral fat
- Targets HIV lipodystrophy
- Stimulates natural GH
Side Effects
- Injection site reactions
- Joint pain
- Mild edema
Contraindications
- Active cancer
- Pregnancy
- Disruption of hypothalamic-pituitary axis
Evidence Summary
FDA-approved based on Phase 3 trials showing visceral adipose tissue reduction in HIV lipodystrophy.
Research
FDA-approved based on Phase 3 trials showing significant reduction in visceral adipose tissue.
View ResearchSafety
FDA-approved. Side effects include injection site reactions and joint pain.
Frequently Asked Questions About Tesamorelin
What is Tesamorelin?
Tesamorelin is a research peptide also known as Egrifta. FDA-approved GHRH analog for HIV-associated lipodystrophy It is studied for its potential therapeutic applications and is available from various research chemical vendors.
How does Tesamorelin work?
Stabilized GHRH analog that stimulates endogenous GH production, targeting visceral fat reduction.
What is the recommended dosage for Tesamorelin?
The commonly studied dosage range for Tesamorelin is 2 mg daily. Dosage protocols vary based on research objectives. Always consult published studies and start with conservative amounts. Tesamorelin should only be used in controlled research settings.
Where can I buy Tesamorelin?
PepsReview indexes Tesamorelin pricing from multiple vendors. Check the Vendors tab above for a price comparison table showing cost per milligram, purity, COA status, and stock availability. Vendor reviews from real users are available on each vendor's profile page.
Is Tesamorelin legal?
US regulatory status: FDA-approved (Egrifta). The legal status of Tesamorelin varies by jurisdiction. In most countries, it is sold as a research chemical, not for human consumption. Always verify the legal status in your country before purchasing.
What are the side effects of Tesamorelin?
Reported side effects include: Injection site reactions, Joint pain, Mild edema. Always review safety data and published studies before use.
Key Research Papers on Tesamorelin
The following peer-reviewed studies and clinical trials are indexed in our research library for Tesamorelin. Each paper links to a detailed summary with key findings, study design, and publication metadata.
- Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy — Drugs, 2011 (300 citations)
- Spotlight on tesamorelin in HIV-associated lipodystrophy — BioDrugs, 2011 (300 citations)
- Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy — Ann Pharmacother, 2012 (280 citations)
Related Growth hormone boosters Peptides
Other peptides in the growth hormone boosters category that may be of interest for comparative research:
Write a Review
Rating Breakdown
Based on 2 reviews.
Reviews
Tesamorelin specifically targets visceral fat. Lost 3 inches off waist in 4 months. FDA-approved for HIV lipodystrophy but works for metabolic syndrome too. GH stimulation is natural and potent.
Tesamorelin works well for visceral fat reduction but the cost is very high. Better results than CJC-1295 for abdominal fat. If you can afford it and have stubborn visceral fat, this is the peptide.